Literature DB >> 3133389

Brucella abortus 1119-3 O-chain polysaccharide to differentiate sera from B. abortus S-19-vaccinated and field-strain-infected cattle by agar gel immunodiffusion.

J W Cherwonogrodzky1, K H Nielsen.   

Abstract

Purified Brucella abortus 1119-3 and Brucella melitensis 16M lipopolysaccharide O-chain polysaccharides were not precipitated in agar gel immunodiffusion by any of 24 sera from vaccinated cattle but were precipitated by 18 of 24 sera from infected cattle. This difference can be used to differentiate sera of cattle vaccinated with B. abortus S-19 from sera of some field-strain-infected cattle.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3133389      PMCID： PMC266545          DOI： 10.1128/jcm.26.6.1120-1123.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

2.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

3.  Brucellosis as a world problem.

Authors:  Z Matyas; T Fujikura
Journal:  Dev Biol Stand       Date:  1984

4.  Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies.

Authors:  D R Bundle; M A Gidney; M B Perry; J R Duncan; J W Cherwonogrodzky
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

5.  Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3.

Authors:  M Caroff; D R Bundle; M B Perry; J W Cherwonogrodzky; J R Duncan
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

6.  Surface antigens of smooth brucellae.

Authors:  R Diaz; L M Jones; D Leong; J B Wilson
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

7.  Vaccination against bovine brucellosis.

Authors:  G G Alton; L A Corner; P Plackett
Journal:  Dev Biol Stand       Date:  1984

8.  Evaluation of a radial immunodiffusion test with polysaccharide B antigen for diagnosis of bovine brucellosis.

Authors:  L M Jones; D T Berman; E Moreno; B L Deyoe; M J Gilsdorf; J D Huber; P Nicoletti
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

9.  The serological response of cattle to vaccines against brucellosis, as measured by the brucellosis radioimmunoassay and other tests.

Authors:  R J Chappel; J Hayes; B A Rogerson; L J Shenfield
Journal:  J Hyg (Lond)       Date:  1982-02

10.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15
View more
  10 in total

1.  Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication.

Authors:  J E Ugalde; C Czibener; M F Feldman; R A Ugalde
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Serological and bacteriological study of swine brucellosis.

Authors:  V R Lord; J W Cherwonogrodzky; M J Marcano; G Melendez
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis.

Authors:  V K Gupta; G Radhakrishnan; J Harms; G Splitter
Journal:  Vaccine       Date:  2012-04-28       Impact factor: 3.641

4.  Thermostable cross-protective subunit vaccine against Brucella species.

Authors:  John W Cherwonogrodzky; Nicole D Barabé; Michelle L Grigat; William E Lee; Robert T Poirier; Scott J Jager; Bradley J Berger
Journal:  Clin Vaccine Immunol       Date:  2014-10-15

5.  Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to Yersinia enterocolitica O:9.

Authors:  P M Muñoz; C M Marín; D Monreal; D González; B Garin-Bastuji; R Díaz; R C Mainar-Jaime; I Moriyón; J M Blasco
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

6.  Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats.

Authors:  E Díaz-Aparicio; V Aragón; C Marín; B Alonso; M Font; E Moreno; S Pérez-Ortiz; J M Blasco; R Díaz; I Moriyón
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzyme-linked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle.

Authors:  B Alonso-Urmeneta; C Marín; V Aragón; J M Blasco; R Díaz; I Moriyón
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats.

Authors:  E Díaz-Aparicio; C Marín; B Alonso-Urmeneta; V Aragón; S Pérez-Ortiz; M Pardo; J M Blasco; R Díaz; I Moriyón
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  Antibody response to Brucella outer membrane proteins in bovine brucellosis: immunoblot analysis and competitive enzyme-linked immunosorbent assay using monoclonal antibodies.

Authors:  A Cloeckaert; P Kerkhofs; J N Limet
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

10.  Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MΔvjbR strain in goats.

Authors:  M Raquel Castaño-Zubieta; Carlos A Rossetti; Daniel G García-González; Estefanía Maurizio; Martha E Hensel; Allison C Rice-Ficht; Thomas A Ficht; Ángela M Arenas-Gamboa
Journal:  Vaccine       Date:  2020-12-13       Impact factor: 3.641
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.